Patent classifications
C07D311/74
NOVEL COMPOUNDS
The invention relates to compounds of formula (I) and related aspects.
##STR00001##
COMPOSITION, FILM, ORGANIC LIGHT EMITTING ELEMENT, METHOD FOR PROVIDING LIGHT EMITTING COMPOSITION, AND PROGRAM
An organic light emitting element produced by using a light emitting composition that contains both a first compound having a PBHT value more than 0.730 and a second compound having ES1 lower than that of the first compound and AEsT less than 0.20 eV is excellent in durability. ES1 is the lowest excited singlet energy level, AEsT is the difference between the lowest excited singlet energy level and the lowest excited triplet energy level.
COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.
BICYCLIC DERIVATIVES
The present invention provides compounds of formula (I):
##STR00001##
which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
BICYCLIC DERIVATIVES
The present invention provides compounds of formula (I):
##STR00001##
which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
COMPOUNDS FOR PROTECTION OF CELLS
This invention is related to a compound with the structural formula (I)
##STR00001## wherein, R1, and R2 are independently selected from the group consisting of C.sub.1-C.sub.6 alkyl and is preferably methyl, ethyl, propyl or isopropyl; R3 is selected from the group consisting of CH.sub.2NHR.sub.9, C(═O)YR.sub.10, —CH2OH
##STR00002##
COMPOUNDS FOR PROTECTION OF CELLS
This invention is related to a compound with the structural formula (I)
##STR00001## wherein, R1, and R2 are independently selected from the group consisting of C.sub.1-C.sub.6 alkyl and is preferably methyl, ethyl, propyl or isopropyl; R3 is selected from the group consisting of CH.sub.2NHR.sub.9, C(═O)YR.sub.10, —CH2OH
##STR00002##
Solvent-free THCA extraction process
A solvent-free method to extract THCA from cannabis, said method comprising: providing a source of THCA-containing cannabis plant; providing a source of natural oil; combining said source of THCA-containing cannabis and said source of natural oil into a blend; milling said blend; optionally, heating the blend during the milling; and extracting a THCA-containing liquid generated during the milling.
Solvent-free THCA extraction process
A solvent-free method to extract THCA from cannabis, said method comprising: providing a source of THCA-containing cannabis plant; providing a source of natural oil; combining said source of THCA-containing cannabis and said source of natural oil into a blend; milling said blend; optionally, heating the blend during the milling; and extracting a THCA-containing liquid generated during the milling.
THERAPEUTIC COMBINATIONS OF CANNABINOIDS WITH CURCUMIN
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing oral formulations as described herein.